⌘K

Home/Insiders/Foy Matthew

FM

SEC Insider//CIK 0001842129

Foy Matthew

CIK 00018421291 companyBOSTON, MA

Transactions

8

Companies

1

Filings

2

CIK

0001842129

Recent Transactions

8 trades

Conversion
Decibel Therapeutics, Inc.
Series D Preferred Stock
2021-02-17−1,737,619→ 0 total
Conversion
Decibel Therapeutics, Inc.
Common Stock
2021-02-17+458,487→ 458,487 total
Conversion
Decibel Therapeutics, Inc.
Common Stock
2021-02-17+247,324→ 705,811 total
Conversion
Decibel Therapeutics, Inc.
Common Stock
2021-02-17+327,852→ 1,033,663 total
Purchase
Decibel Therapeutics, Inc.
Common Stock
2021-02-17$18.00/sh+150,000→ 1,183,663 total
Conversion
Decibel Therapeutics, Inc.
Series A Preferred Stock
2021-02-17−7,119,852→ 0 total
Conversion
Decibel Therapeutics, Inc.
Series C Preferred Stock
2021-02-17−3,125,000→ 0 total
Award
Decibel Therapeutics, Inc.
Stock Option (right to buy)
2021-02-11+20,000→ 20,000 total

Companies

1

Decibel Therapeutics, Inc.
Director, 10% Owner

Recent Filings

2

Address

C/O DECIBEL THERAPEUTICS, INC. 1325 BOYLSTON STREET, SUITE 500

BOSTON, MA, 02215

View on SEC.gov